K. Malki

Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma

C. Paret, J. Faber, Daniel-Christoph Wagner, 2020, Cancers.

GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype

C. Sommer, K. Frauenknecht, C. Paret, 2022, Cancers.

Benefits of Exercise Training for Children and Adolescents Undergoing Cancer Treatment: Results From the Randomized Controlled MUCKI Trial

C. Paret, F. Baumann, W. Bloch, 2020, Frontiers in Pediatrics.

Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy

C. Sommer, C. Paret, T. Pietsch, 2016, Oncotarget.

Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice

C. Sommer, A. Waisman, K. Frauenknecht, 2013, Journal of Neuroimmune Pharmacology.